5AT-10876-10254

3 vaccinations 7 coded responses 32 check-ins 7 free-text entries 2 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 010 / MA
Registered: 2020-12-17

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Registered in v-safe
2020-12-17
Dose 1 — Pfizer-BioNTech
2020-12-17
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2020-12-18
Survey response — days 1–6 daily, dose 1
MedDRA: Breast feeding — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Breast feeding

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-19
Survey response — days 1–6 daily, dose 1
MedDRA: Breast feeding — Feeling: Good · Fatigue or tiredness

Free text: Breastfeeding

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-26
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Survey response — day 14, dose 1
MedDRA: Arthralgia — Feeling: Good

Free text: Joint pain, bilateral knees

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-08
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-01-09
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Fever · Headache, Fatigue or tiredness

Free text: Light headed

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Redness · None

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-15
Health check-in — day 7, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-22
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-09
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-01
Dose 3 — Pfizer-BioNTech
2021-10-01
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-10-03
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Pain in axillary area. Swollen lymph nodes.

MedDRA releases: 2024-11 · check-in free text available
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-10-05
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-10
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-16
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-22
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-11-12
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-12-31
Survey response — 3 months, dose 3
MedDRA: Foetal growth restriction, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Pregnancy- diagnosed with severe IUGR

MedDRA releases: 2024-11 · check-in free text available
2021-12-31
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-06
Call 1 — Left Voicemail
2022-04-01
Survey response — 6 months, dose 3
MedDRA: Foetal growth restriction — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization

Free text: Diagnosed with IUGR of pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-04-01
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
2022-04-06
Call successful
Participant prefers to complete VAERS report online
2022-10-04
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech
3	2021-10-01	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-12-31	Successful	Participant prefers to complete VAERS report online
2022-04-01	Successful 2022-04-06	Participant prefers to complete VAERS report online

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-18

Systemic reaction (other): Breast feeding

2020-12-19

Systemic reaction (other): Breastfeeding

Release 1 — day 14, dose 1

2020-12-31

Symptoms: Joint pain, bilateral knees

Release 1 — days 1–6 daily, dose 2

2021-01-09

Systemic reaction (other): Light headed

Release 9 — days 1–6 daily, dose 3

2021-10-03

Systemic reaction (other): Pain in axillary area. Swollen lymph nodes.

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: Pregnancy- diagnosed with severe IUGR

Release 11 — 6 months, dose 3

2022-04-01

Symptoms: Diagnosed with IUGR of pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Arthralgia	✓	✓	✓
SD	Foetal growth restriction	·	·	✓
SD	Pregnancy	·	·	✓
SRO	Axillary pain	·	·	✓
SRO	Breast feeding	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Exposure via breast milk	○	○	○
SRO	Lymphadenopathy	·	·	✓
SRO	Maternal exposure during breast feeding	○	○	○

✓ active code · ○ coded but marked inactive · blank = not in that release